• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    Oncothyreon Inc (ONTY)

    -NasdaqGS
    1.65 Up 0.04(2.48%) 4:00PM EDT
    |After Hours : 1.62 Down 0.04 (2.12%) 5:00PM EDT
    Add to Portfolio
    Prev Close:1.61
    Open:1.62
    Bid:1.55 x 4000
    Ask:1.73 x 2000
    1y Target Est:3.50
    Beta:1.52
    Earnings Date:Apr 29 - May 4 (Est.)
    Day's Range:1.57 - 1.66
    52wk Range:1.48 - 3.60
    Volume:943,767
    Avg Vol (3m):820,942
    Market Cap:168.80M
    P/E (ttm):N/A
    EPS (ttm):-0.64
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ONTY

    Comparison

    Symbol% ChgMkt Cap
    ONTYUp 2.48%168.80M
    GSKUp 0.77%113.11B
    RHHBYDown 0.23%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:08-May-95

    Analysts

    Annual EPS Est (Dec-15) :-0.34
    Quarterly EPS Est (Mar-15) :-0.08
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Oncothyreon Inc, a clinical-stage biopharmaceutical company, develops therapeutic products for the treatment of cancer. Its product candidate includes Tecemotide, a vaccine for the treatment of non-small cell lung cancer. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback